About: Measures in the first year of therapy predict the response to interferon β in MS

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Measures in the first year of therapy predict the response to interferon β in MS Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) հոդված (hy) wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2009 (uk) im Juni 2009 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57601917-260DD878-76FD-4EEA-B4B7-DFD42FF4C669
publication date	2009-07-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q57601917-03A8BD72-363C-4C70-9474-459498FA5542 wds:Q57601917-0587E25A-737E-4937-A298-2E86ABFD8DCF wds:Q57601917-15AF15A3-4349-4FDD-AD78-C0AD4012088A wds:Q57601917-1DDE9100-7B86-49ED-B366-07C54E6E94B2 wds:Q57601917-30380FE4-8227-4E6B-8097-DC7244D2ADF6 wds:Q57601917-33E2FA90-2993-4BB7-9C86-30EE624698F9 wds:Q57601917-46056B31-4AAD-4AEB-AC35-140F515820A0 wds:Q57601917-4A96DD45-7F5E-4CB1-862F-125430786367 wds:Q57601917-4E7D3E59-404C-4091-A240-2DA54852E972 wds:Q57601917-4EFD2C87-C8FD-4F3C-B2F6-FDC0F73FC531 wds:Q57601917-54C52E1B-19F5-4639-B7C8-9BF7F6BE9C6F wds:Q57601917-55DC1492-5288-4503-8668-2CFEF68F8199 wds:Q57601917-647EFEEF-01C8-4D71-9919-F148F4860ECA wds:Q57601917-6D1C321E-1507-4009-B6DC-247B9FE30D05 wds:Q57601917-7225ECFB-911B-4F38-A0DD-29337C8EC5FF wds:Q57601917-7AE00CCF-970D-4118-9C00-D920A22C7536 wds:Q57601917-905E62B4-1337-4B69-A600-035D0006FDBF wds:Q57601917-941CF575-6731-46CD-B14D-78907B2BC12A wds:Q57601917-B08A8CF0-BB8E-4099-B192-278A1AE9C4E9 wds:Q57601917-E9C95FE8-E446-4116-B201-BB64B662EB1B wds:Q57601917-FE7FB0A3-C2C6-4E8F-9243-F3E1EA8320DD
cites work	A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis Defining interferon beta response status in multiple sclerosis patients. Transcription-based prediction of response to IFNbeta using supervised computational methods Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients Clinical characteristics of responders to interferon therapy for relapsing MS. A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis A solution to the problem of separation in logistic regression. Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis. Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients Using measurements of neutralizing antibodies: the challenge of IFN-beta therapy Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria Disability as an outcome in MS clinical trials Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
author name string	wds:Q57601917-9B79FD58-B66A-4B61-BF72-86BE2EA5A675 wds:Q57601917-B255227A-8AA9-40AE-B5C5-13DFBC90B851 wds:Q57601917-CD07D278-C3BB-47A1-8F0E-A19C618A254A wds:Q57601917-D2CC7E65-E7AC-4CE4-8DB2-B4A825D4EC63 wds:Q57601917-E084A759-6D90-4719-871F-AEC233283792
author name string	A Rovira C Nos M Comabella X Aymerich J Castilló
rdfs:label	Measures in the first year of therapy predict the response to interferon β in MS (en) Measures in the first year of therapy predict the response to interferon β in MS (nl)
skos:prefLabel	Measures in the first year of therapy predict the response to interferon β in MS (en) Measures in the first year of therapy predict the response to interferon β in MS (nl)
name	Measures in the first year of therapy predict the response to interferon β in MS (en) Measures in the first year of therapy predict the response to interferon β in MS (nl)
author	wds:Q57601917-18193D3C-902F-47F0-90A7-5EBF364E3BDD wds:Q57601917-69348639-2C03-4D17-BD19-0FD9B46B5B98 wds:Q57601917-9D8A8BE7-97FD-4049-9FFB-DE47442C8869 wds:Q57601917-F7E72599-4C85-4F40-AAE7-83FEB05A33F6 wds:Q57601917-FDD91B44-5C8E-49F6-9ACB-D81121ECBFFF
author	Jaume Sastre Garriga Alejandro Horga Xavier Montalban Mar Tintoré Jordi Rio
title	wds:Q57601917-7CD841D5-3161-4DEE-AB1E-C4D82AA43B61
title	Measures in the first year of therapy predict the response to interferon beta in MS (en)
page(s)	wds:Q57601917-75D93808-3105-4C6A-A181-EAA3DC93B8EB
page(s)	848-853
instance of	wds:Q57601917-73B4116C-061A-4635-9B69-5D0B9646448F
instance of	scholarly article
PubMed ID	wds:Q57601917-C7EF28E8-AF8E-42D4-A692-261C45FA6C94
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19542263
PubMed ID	19542263
published in	wds:Q57601917-034A4A19-2A1A-47DC-BDED-CCC436370543
published in	Multiple Sclerosis Journal
issue	wds:Q57601917-7E5061BC-0659-4695-8838-C48CE4D1F5FC
volume	wds:Q57601917-D2E4275F-8B2B-4E5C-BD3E-A2FABB8A470D
issue	7
volume	15
DOI	wds:Q57601917-DAB0D5DB-7101-4165-BDBC-48FEC99CB7CC
DOI	http://dx.doi.org/10.1177/1352458509104591
DOI	10.1177/1352458509104591
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57601917
is cites work of	Clinical correlates of grey matter pathology in multiple sclerosis Predictive value of early brain atrophy on response in patients treated with interferon β Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom Risk acceptance in multiple sclerosis patients on natalizumab treatment. MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software